128 related articles for article (PubMed ID: 12213261)
1. 5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline(2) binding site ligand: in vitro and in vivo characterisation in rat brain.
Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
Neuropharmacology; 2002 Jul; 43(1):75-83. PubMed ID: 12213261
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites.
Paterson LM; Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
Neuropharmacology; 2007 Feb; 52(2):395-404. PubMed ID: 17045310
[TBL] [Abstract][Full Text] [Related]
3. In vivo estimation of imidazoline(2) binding site turnover.
Paterson LM; Robinson ES; Nutt DJ; Hudson AL
Ann N Y Acad Sci; 2003 Dec; 1009():367-70. PubMed ID: 15028614
[TBL] [Abstract][Full Text] [Related]
4. Distribution of [(3)H]BU224, a selective imidazoline I(2) binding site ligand, in rat brain.
Robinson ES; Tyacke RJ; Nutt DJ; Hudson AL
Eur J Pharmacol; 2002 Aug; 450(1):55-60. PubMed ID: 12176109
[TBL] [Abstract][Full Text] [Related]
5. Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors.
Lione LA; Nutt DJ; Hudson AL
Eur J Pharmacol; 1998 Jul; 353(1):123-35. PubMed ID: 9721049
[TBL] [Abstract][Full Text] [Related]
6. Relationship between imidazoline(2) sites and monoamine oxidase.
Paterson LM; Tyacke RJ; Nutt DJ; Hudson AL
Ann N Y Acad Sci; 2003 Dec; 1009():353-6. PubMed ID: 15028610
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of imidazoline I2 binding sites in pig brain.
Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
[TBL] [Abstract][Full Text] [Related]
8. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
Hosseini AR; King PR; Louis WJ; Gundlach AL
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
[TBL] [Abstract][Full Text] [Related]
10. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
Alemany R; Olmos G; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
[TBL] [Abstract][Full Text] [Related]
11. [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors.
Lione LA; Nutt DJ; Hudson AL
Eur J Pharmacol; 1996 May; 304(1-3):221-9. PubMed ID: 8813605
[TBL] [Abstract][Full Text] [Related]
12. Differential [(3)H]idazoxan and [(3)H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) binding to imidazoline I(2) receptors in human postmortem frontal cortex.
Callado LF; Maeztu AI; Ballesteros J; Gutiérrez M; Meana JJ
Eur J Pharmacol; 2001 Jul; 423(2-3):109-14. PubMed ID: 11448473
[TBL] [Abstract][Full Text] [Related]
13. Region-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I(2) sites.
MacInnes N; Handley SL
Eur J Pharmacol; 2001 Oct; 428(2):221-5. PubMed ID: 11675039
[TBL] [Abstract][Full Text] [Related]
14. Novel ligands for the investigation of imidazoline receptors and their binding proteins.
Hudson AL; Tyacke RJ; Lalies MD; Davies N; Finn DP; Marti O; Robinson E; Husbands S; Minchin MC; Kimura A; Nutt DJ
Ann N Y Acad Sci; 2003 Dec; 1009():302-8. PubMed ID: 15028604
[TBL] [Abstract][Full Text] [Related]
15. Effects of I
Keller B; García-Sevilla JA
Neurochem Int; 2017 Sep; 108():169-176. PubMed ID: 28342965
[TBL] [Abstract][Full Text] [Related]
16. 2-(4,5-dihydro-1H-imidazol-2-yl)indazole (indazim) derivatives as selective I(2) imidazoline receptor ligands.
Saczewski F; Hudson AL; Tyacke RJ; Nutt DJ; Man J; Tabin P; Saczewski J
Eur J Pharm Sci; 2003 Oct; 20(2):201-8. PubMed ID: 14550886
[TBL] [Abstract][Full Text] [Related]
17. In vivo effects of the I(2)-alkylating agent BU99006 on the immunodensity of imidazoline receptor proteins in the mouse brain.
Garcia-Sevilla JA; Ferrer-Alcon M
Ann N Y Acad Sci; 2003 Dec; 1009():323-31. PubMed ID: 15028606
[TBL] [Abstract][Full Text] [Related]
18. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine.
Wiest SA; Steinberg MI
Life Sci; 1997; 60(9):605-15. PubMed ID: 9048963
[TBL] [Abstract][Full Text] [Related]
19. Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo.
Sastre-Coll A; Esteban S; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):50-62. PubMed ID: 10463334
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of 2-(2-benzofuranyl)-2-imidazoline (2-BFI) induces region-specific increases in [3H]2-BFI binding to rat central imidazoline I2 sites.
MacInnes N; Handley SL
Neurosci Lett; 2004 Jun; 363(1):11-3. PubMed ID: 15157985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
